查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
光線動態療法的全球市場 - 產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)
市場調查報告書
商品編碼
1121686

光線動態療法的全球市場 - 產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)

Photodynamic Therapy Market (Product Type: Photosensitizer Drugs and Devices; and Application: Cancer, Actinic Keratosis, Psoriasis, Acne, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 243 Pages | 商品交期: 2-10個工作天內

價格

本報告提供全球光線動態療法市場相關調查分析，提供市場趨勢，市場區隔分析，地區分析，企業簡介等資訊。

目錄

第1章 序文

第2章 前提條件與調查手法

第3章 摘要整理:全球光線動態療法市場

第4章 市場概要

  • 簡介
    • 市場區隔定義
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 全球光線動態療法市場分析與預測(2017年～2031年)
    • 市場收益預測

第5章 主要洞察

  • 主要的合併和收購
  • 技術進步
  • COVID-19影響分析

第6章 全球光線動態療法市場分析與預測:各產品類型

  • 簡介和定義
  • 主要的調查結果/發展
  • 市場價值預測(2017年～2031年):各產品類型
    • 光敏化劑
    • 設備
  • 市場魅力分析:各產品類型

第7章 全球光線動態療法市場分析與預測:各用途

  • 簡介和定義
  • 主要的調查結果/發展
  • 市場價值預測(2017年～2031年):各用途
    • 癌症
    • 光化性角化症(AK)
    • 乾癬
    • 粉刺
    • 其他
  • 市場魅力分析:各用途

第8章 全球光線動態療法市場分析與預測:各終端用戶

  • 簡介和定義
  • 主要的調查結果/發展
  • 市場價值預測(2017年～2031年):各終端用戶
    • 醫院
    • CDC
    • CCC
    • 其他
  • 市場魅力分析:各終端用戶

第9章 全球光線動態療法市場分析與預測:各地區

  • 主要的調查結果
  • 市場價值預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力分析:各地區

第10章 北美的光線動態療法市場分析與預測

  • 簡介
    • 主要的調查結果
  • 市場價值預測(2017年～2031年):各產品類型
    • 光敏化劑
    • 設備
  • 市場價值預測(2017年～2031年):各用途
    • 癌症
    • 光化性角化症(AK)
    • 乾癬
    • 粉刺
    • 其他
  • 市場價值預測(2017年～2031年):各終端用戶
    • 醫院
    • CDC
    • CCC
    • 其他
  • 市場價值預測(2017年～2031年):各國
    • 美國
    • 加拿大
  • 市場魅力分析
    • 各產品類型
    • 各用途
    • 各終端用戶
    • 各國

第11章 歐洲的光線動態療法市場分析與預測

第12章 亞太地區的光線動態療法市場分析與預測

第13章 南美的光線動態療法市場分析與預測

第14章 中東·非洲的光線動態療法市場分析與預測

第15章 競爭情形

  • 市場企業 - 競爭矩陣(各階層·企業規模)
  • 市場佔有率分析(2021年):各企業
  • 企業簡介
    • Galderma Laboratories, LP
    • Biofrontera AG
    • Excel Lasers Limited
    • LUMIBIRD group(Quantel Medical)
    • Modulight Corporation
    • Quest PharmaTech, Inc.
    • Theralase Technologies, Inc.
    • SUS Advancing Technology Co., Ltd.
Product Code: TMRGL69615

The report provides revenue of the global photodynamic therapy market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global photodynamic therapy market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the photodynamic therapy market.

The report delves into the competitive landscape of the global photodynamic therapy market. Key players operating in the global photodynamic therapy market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global photodynamic therapy market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Photodynamic Therapy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Photodynamic Therapy Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Mergers & Acquisitions
  • 5.2. Technological Advancements
  • 5.3. Covid-19 Impact Analysis

6. Global Photodynamic Therapy Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Photosensitizer Drugs
      • 6.3.1.1. Porphyrin Derivative (PD)
        • 6.3.1.1.1. Hematoporphyrin Derivative (HpD)
        • 6.3.1.1.2. Benzoporphyrin Derivative (BPD)
        • 6.3.1.1.3. Texaphyrins
        • 6.3.1.1.4. Others
      • 6.3.1.2. Aminolevulinic acid (ALA)
      • 6.3.1.3. Chlorines
      • 6.3.1.4. Others
    • 6.3.2. Devices
      • 6.3.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
      • 6.3.2.2. Diode Laser
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Photodynamic Therapy Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Cancer
      • 7.3.1.1. Basal Cell Carcinoma
      • 7.3.1.2. Non-Small Cell Lung Cancer
      • 7.3.1.3. Head & Neck Cancer
      • 7.3.1.4. Others
    • 7.3.2. Actinic Keratosis (AK)
    • 7.3.3. Psoriasis
    • 7.3.4. Acne
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Photodynamic Therapy Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. C&DC
    • 8.3.3. CCC
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Photodynamic Therapy Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Photodynamic Therapy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2031
    • 10.2.1. Photosensitizer Drugs
      • 10.2.1.1. Porphyrin Derivative (PD)
        • 10.2.1.1.1. Hematoporphyrin Derivative (HpD)
        • 10.2.1.1.2. Benzoporphyrin Derivative (BPD)
        • 10.2.1.1.3. Texaphyrins
        • 10.2.1.1.4. Others
      • 10.2.1.2. Aminolevulinic acid (ALA)
      • 10.2.1.3. Chlorines
      • 10.2.1.4. Others
    • 10.2.2. Devices
      • 10.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
      • 10.2.2.2. Diode Laser
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Cancer
      • 10.3.1.1. Basal Cell Carcinoma
      • 10.3.1.2. Non-Small Cell Lung Cancer
      • 10.3.1.3. Head & Neck Cancer
      • 10.3.1.4. Others
    • 10.3.2. Actinic Keratosis (AK)
    • 10.3.3. Psoriasis
    • 10.3.4. Acne
    • 10.3.5. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. C&DC
    • 10.4.3. CCC
    • 10.4.4. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Photodynamic Therapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Photosensitizer Drugs
      • 11.2.1.1. Porphyrin Derivative (PD)
        • 11.2.1.1.1. Hematoporphyrin Derivative (HpD)
        • 11.2.1.1.2. Benzoporphyrin Derivative (BPD)
        • 11.2.1.1.3. Texaphyrins
        • 11.2.1.1.4. Others
      • 11.2.1.2. Aminolevulinic acid (ALA)
      • 11.2.1.3. Chlorines
      • 11.2.1.4. Others
    • 11.2.2. Devices
      • 11.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
      • 11.2.2.2. Diode Laser
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Cancer
      • 11.3.1.1. Basal Cell Carcinoma
      • 11.3.1.2. Non-Small Cell Lung Cancer
      • 11.3.1.3. Head & Neck Cancer
      • 11.3.1.4. Others
    • 11.3.2. Actinic Keratosis (AK)
    • 11.3.3. Psoriasis
    • 11.3.4. Acne
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. C&DC
    • 11.4.3. CCC
    • 11.4.4. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Photodynamic Therapy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Photosensitizer Drugs
      • 12.2.1.1. Porphyrin Derivative (PD)
        • 12.2.1.1.1. Hematoporphyrin Derivative (HpD)
        • 12.2.1.1.2. Benzoporphyrin Derivative (BPD)
        • 12.2.1.1.3. Texaphyrins
        • 12.2.1.1.4. Others
      • 12.2.1.2. Aminolevulinic acid (ALA)
      • 12.2.1.3. Chlorines
      • 12.2.1.4. Others
    • 12.2.2. Devices
      • 12.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
      • 12.2.2.2. Diode Laser
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Cancer
      • 12.3.1.1. Basal Cell Carcinoma
      • 12.3.1.2. Non-Small Cell Lung Cancer
      • 12.3.1.3. Head & Neck Cancer
      • 12.3.1.4. Others
    • 12.3.2. Actinic Keratosis (AK)
    • 12.3.3. Psoriasis
    • 12.3.4. Acne
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. C&DC
    • 12.4.3. CCC
    • 12.4.4. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Photodynamic Therapy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Photosensitizer Drugs
      • 13.2.1.1. Porphyrin Derivative (PD)
        • 13.2.1.1.1. Hematoporphyrin Derivative (HpD)
        • 13.2.1.1.2. Benzoporphyrin Derivative (BPD)
        • 13.2.1.1.3. Texaphyrins
        • 13.2.1.1.4. Others
      • 13.2.1.2. Aminolevulinic acid (ALA)
      • 13.2.1.3. Chlorines
      • 13.2.1.4. Others
    • 13.2.2. Devices
      • 13.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
      • 13.2.2.2. Diode Laser
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Cancer
      • 13.3.1.1. Basal Cell Carcinoma
      • 13.3.1.2. Non-Small Cell Lung Cancer
      • 13.3.1.3. Head & Neck Cancer
      • 13.3.1.4. Others
    • 13.3.2. Actinic Keratosis (AK)
    • 13.3.3. Psoriasis
    • 13.3.4. Acne
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. C&DC
    • 13.4.3. CCC
    • 13.4.4. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. Photosensitizer Drugs
      • 14.2.1.1. Porphyrin Derivative (PD)
        • 14.2.1.1.1. Hematoporphyrin Derivative (HpD)
        • 14.2.1.1.2. Benzoporphyrin Derivative (BPD)
        • 14.2.1.1.3. Texaphyrins
        • 14.2.1.1.4. Others
      • 14.2.1.2. Aminolevulinic acid (ALA)
      • 14.2.1.3. Chlorines
      • 14.2.1.4. Others
    • 14.2.2. Devices
      • 14.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
      • 14.2.2.2. Diode Laser
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Cancer
      • 14.3.1.1. Basal Cell Carcinoma
      • 14.3.1.2. Non-Small Cell Lung Cancer
      • 14.3.1.3. Head & Neck Cancer
      • 14.3.1.4. Others
    • 14.3.2. Actinic Keratosis (AK)
    • 14.3.3. Psoriasis
    • 14.3.4. Acne
    • 14.3.5. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. C&DC
    • 14.4.3. CCC
    • 14.4.4. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2021
  • 15.3. Company Profiles
    • 15.3.1. Galderma Laboratories, L.P.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Biofrontera AG
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. 15.3.1.5. Recent Developments
    • 15.3.3. Excel Lasers Limited
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. LUMIBIRD group (Quantel Medical)
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Modulight Corporation
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Quest PharmaTech, Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Theralase Technologies, Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. SUS Advancing Technology Co., Ltd.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments

List of Tables

  • Table 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
  • Table 03: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
  • Table 04: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
  • Table 05: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 06: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
  • Table 07: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 08: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region , 2017-2031
  • Table 09: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country, 2017-2031
  • Table 10: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type,2017-2031
  • Table 11: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
  • Table 12: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
  • Table 13: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices,2017-2031
  • Table 14: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 15: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
  • Table 16: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 19: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drug, 2017-2031
  • Table 20: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
  • Table 21: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
  • Table 22: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 23: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
  • Table 24: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 27: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
  • Table 28: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
  • Table 29: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
  • Table 30: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 31: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
  • Table 32: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 33: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 34: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 35: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
  • Table 36: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
  • Table 37: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
  • Table 38: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 39: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
  • Table 40: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 41: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 42: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 43: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
  • Table 44: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
  • Table 45: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
  • Table 46: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 47: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
  • Table 48: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Photodynamic Therapy Market Value Share (%), by Product Type, 2021
  • Figure 03: Global Photodynamic Therapy Market Value Share (%), by Drugs, 2021
  • Figure 04: Global Photodynamic Therapy Market Value Share (%), by Application, 2021
  • Figure 05: Global Photodynamic Therapy Market Value Share (%), by Region, 2021
  • Figure 06: Global Photodynamic Therapy Market Value Share (%), by Product Type, 2017 and 2031
  • Figure 07: Global Photodynamic Therapy Market Value Share (%), by Photosensitizer Drugs, 2017 and 2031
  • Figure 08: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Photosensitizer Drugs, 2017-2031
  • Figure 09: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Devices, 2017-2031
  • Figure 10: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Porphyrin Derivative (PD), 2017-2031
  • Figure 11: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aminolevulinic Acid (ALA), 2017-2031
  • Figure 12: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chlorines, 2017-2031
  • Figure 13: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
  • Figure 14: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DFOLDD, 2017-2031
  • Figure 15: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diode Laser, 2017-2031
  • Figure 16: Global Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2021-2031
  • Figure 17: Global Photodynamic Therapy Market Attractiveness Analysis, by Photosensitizer Drugs, 2021-2031
  • Figure 18: Global Photodynamic Therapy Market Attractiveness Analysis, by Devices, 2021-2031
  • Figure 19: Global Photodynamic Therapy Market Value Share (%), by Application, 2017 and 2031
  • Figure 20: Global Photodynamic Therapy Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 21: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer, 2017-2031
  • Figure 22: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Actinic Keratosis (AK), 2017-2031
  • Figure 23: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Psoriasis, 2017-2031
  • Figure 24: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Acne, 2017-2031
  • Figure 25: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
  • Figure 26: Global Photodynamic Therapy Market Value Share (%), by End-user, 2017 and 2031
  • Figure 27: Global Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 28: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2031
  • Figure 29: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cosmetics & Dermatology Clinics, 2017-2031
  • Figure 30: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer Treatment Centers, 2017-2031
  • Figure 31: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
  • Figure 32: Global Photodynamic Therapy Market Value Share Analysis, by Region, 2017 and 2031
  • Figure 33: Global Photodynamic Therapy Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 34: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 35: North America Photodynamic Therapy Market Value Share (%), by Country, 2017 and 2031
  • Figure 36: North America Photodynamic Therapy Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 37: North America Photodynamic Therapy Market Value Share, by Product Type, 2017and 2031
  • Figure 38: North America Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 39: North America Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
  • Figure 40: North America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 41: North America Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
  • Figure 42: North America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 43: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 44: Europe Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017and 2031
  • Figure 45: Europe Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 46: Europe Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
  • Figure 47: Europe Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 48: Europe Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
  • Figure 49: Europe Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 50: Europe Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
  • Figure 51: Europe Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 52: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 53: Asia Pacific Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031
  • Figure 54: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 55: Asia Pacific Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
  • Figure 56: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 57: Asia Pacific Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
  • Figure 58: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 59: Asia Pacific Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
  • Figure 60: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 61: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 62: Latin America Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031
  • Figure 63: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 64: Latin America Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
  • Figure 65: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2017-2031
  • Figure 66: Latin America Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
  • Figure 67: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 68: Latin America Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
  • Figure 69: Latin America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 70: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 71: Middle East & Africa Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031
  • Figure 72: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 73: Middle East & Africa Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
  • Figure 74: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 75: Middle East & Africa Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
  • Figure 76: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 77: Middle East & Africa Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
  • Figure 78: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031